Table 2.
CR | PR | SD | PD | RR (%) | DCR (%) | |
---|---|---|---|---|---|---|
GP | 2 | 25 | 36 | 37 | 27 | 63 |
TP | 5 | 47 | 23 | 25 | 52 | 75 |
P-value | <0.001 | 0.067 |
Notes: GP group refer to the group of patients treated with gemcitabine in combination with cisplatin. TP group refer to the group of patients treated with abraxane in combination with cisplatin.
Abbreviations: CR, complete remission; PR, partial response; SD, stable disease; PD, progressive disease; RR, response rate; DCR, disease control rate.